Masimo Co. (NASDAQ:MASI) Given Consensus Recommendation of “Buy” by Brokerages

Shares of Masimo Co. (NASDAQ:MASI) have received an average recommendation of “Buy” from the eight ratings firms that are covering the company, MarketBeat.com reports. Three analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 12-month price target among brokers that have covered the stock in the last year is $164.20.

A number of research firms have weighed in on MASI. BidaskClub raised Masimo from a “sell” rating to a “hold” rating in a report on Wednesday, November 20th. ValuEngine downgraded Masimo from a “buy” rating to a “hold” rating in a research report on Wednesday, October 2nd.

In other news, EVP Anand Sampath sold 15,000 shares of Masimo stock in a transaction that occurred on Wednesday, November 20th. The shares were sold at an average price of $155.00, for a total value of $2,325,000.00. Following the completion of the transaction, the executive vice president now owns 27,518 shares in the company, valued at $4,265,290. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, COO Bilal Muhsin sold 3,000 shares of the business’s stock in a transaction that occurred on Monday, November 18th. The stock was sold at an average price of $155.00, for a total value of $465,000.00. In the last ninety days, insiders sold 43,087 shares of company stock worth $6,530,607. 11.50% of the stock is owned by insiders.

A number of institutional investors and hedge funds have recently modified their holdings of MASI. First Hawaiian Bank increased its stake in shares of Masimo by 20.1% in the second quarter. First Hawaiian Bank now owns 2,330 shares of the medical equipment provider’s stock valued at $347,000 after buying an additional 390 shares in the last quarter. NEXT Financial Group Inc grew its stake in shares of Masimo by 172.0% during the second quarter. NEXT Financial Group Inc now owns 544 shares of the medical equipment provider’s stock valued at $81,000 after purchasing an additional 344 shares during the last quarter. New York State Teachers Retirement System grew its stake in shares of Masimo by 7.1% during the second quarter. New York State Teachers Retirement System now owns 71,000 shares of the medical equipment provider’s stock valued at $10,566,000 after purchasing an additional 4,700 shares during the last quarter. Machina Capital S.A.S. acquired a new stake in shares of Masimo in the second quarter valued at approximately $209,000. Finally, Commonwealth Equity Services LLC increased its holdings in shares of Masimo by 5.7% in the second quarter. Commonwealth Equity Services LLC now owns 4,890 shares of the medical equipment provider’s stock valued at $727,000 after purchasing an additional 264 shares in the last quarter. Hedge funds and other institutional investors own 82.73% of the company’s stock.

Shares of Masimo stock traded up $1.76 during trading on Friday, hitting $157.37. 268,560 shares of the company’s stock traded hands, compared to its average volume of 381,884. The firm’s fifty day moving average price is $148.43 and its 200 day moving average price is $148.16. Masimo has a twelve month low of $98.23 and a twelve month high of $160.25. The company has a market cap of $8.27 billion, a PE ratio of 51.94, a PEG ratio of 2.12 and a beta of 1.15.

Masimo (NASDAQ:MASI) last posted its quarterly earnings results on Wednesday, October 30th. The medical equipment provider reported $0.76 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.73 by $0.03. The firm had revenue of $229.01 million during the quarter, compared to analyst estimates of $221.92 million. Masimo had a net margin of 20.83% and a return on equity of 17.32%. The company’s quarterly revenue was up 8.8% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.71 earnings per share. As a group, research analysts predict that Masimo will post 3.17 EPS for the current year.

About Masimo

Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive monitoring technologies worldwide. The company offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry.

Recommended Story: Bond

Analyst Recommendations for Masimo (NASDAQ:MASI)

Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.